Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18473350rdf:typepubmed:Citationlld:pubmed
pubmed-article:18473350lifeskim:mentionsumls-concept:C0281361lld:lifeskim
pubmed-article:18473350lifeskim:mentionsumls-concept:C0085862lld:lifeskim
pubmed-article:18473350lifeskim:mentionsumls-concept:C1299583lld:lifeskim
pubmed-article:18473350lifeskim:mentionsumls-concept:C1333903lld:lifeskim
pubmed-article:18473350lifeskim:mentionsumls-concept:C1514474lld:lifeskim
pubmed-article:18473350lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:18473350lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:18473350lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:18473350lifeskim:mentionsumls-concept:C1608386lld:lifeskim
pubmed-article:18473350lifeskim:mentionsumls-concept:C1549571lld:lifeskim
pubmed-article:18473350lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:18473350pubmed:issue2lld:pubmed
pubmed-article:18473350pubmed:dateCreated2008-7-15lld:pubmed
pubmed-article:18473350pubmed:abstractTextHigh mobility group AT-hook 1 (HMGA1) proteins are architectural transcription factors that are overexpressed by pancreatic adenocarcinomas. The authors hypothesized that tumor HMGA1 status represents a novel prognostic marker in pancreatic adenocarcinoma. They also tested the hypothesis that HMGA1 promotes anchorage-independent cellular proliferation and in vivo tumorigenicity.lld:pubmed
pubmed-article:18473350pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18473350pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18473350pubmed:languageenglld:pubmed
pubmed-article:18473350pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18473350pubmed:citationSubsetAIMlld:pubmed
pubmed-article:18473350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18473350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18473350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18473350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18473350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18473350pubmed:statusMEDLINElld:pubmed
pubmed-article:18473350pubmed:monthJullld:pubmed
pubmed-article:18473350pubmed:issn0008-543Xlld:pubmed
pubmed-article:18473350pubmed:authorpubmed-author:RedstonMarkMlld:pubmed
pubmed-article:18473350pubmed:authorpubmed-author:RochaFlavioFlld:pubmed
pubmed-article:18473350pubmed:authorpubmed-author:MatrosEvanElld:pubmed
pubmed-article:18473350pubmed:authorpubmed-author:LiauSiong-Sen...lld:pubmed
pubmed-article:18473350pubmed:authorpubmed-author:WhangEdwardElld:pubmed
pubmed-article:18473350pubmed:issnTypePrintlld:pubmed
pubmed-article:18473350pubmed:day15lld:pubmed
pubmed-article:18473350pubmed:volume113lld:pubmed
pubmed-article:18473350pubmed:ownerNLMlld:pubmed
pubmed-article:18473350pubmed:authorsCompleteYlld:pubmed
pubmed-article:18473350pubmed:pagination302-14lld:pubmed
pubmed-article:18473350pubmed:dateRevised2011-3-1lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:meshHeadingpubmed-meshheading:18473350...lld:pubmed
pubmed-article:18473350pubmed:year2008lld:pubmed
pubmed-article:18473350pubmed:articleTitleHigh mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.lld:pubmed
pubmed-article:18473350pubmed:affiliationDepartment of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.lld:pubmed
pubmed-article:18473350pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18473350pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18473350pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:3159entrezgene:pubmedpubmed-article:18473350lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18473350lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18473350lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18473350lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18473350lld:pubmed